elismetrep   Click here for help

GtoPdb Ligand ID: 9774

Synonyms: example 104 [WO2012124825]
Compound class: Synthetic organic
Comment: Elismetrep (example 104) is claimed in patent WO2012124825 as a TRPM8 antagonist [1]. TRPM8 antagonists have been considered as non-opioid analgesics for the treatment of chronic pain, or as agents to combat cold induced allodynia and hyperalgesia (reviewed in [2]). TRPM8 antagonists can cause an adverse effect of hot sensation or induce hypothermia.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 9
Topological polar surface area 105.18
Molecular weight 542.11
XLogP 7.37
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC(=O)c1ccc(cc1)S(=O)(=O)N(c1ncc2c(c1C1CC1)cccc2)Cc1ccc(cc1)OC(F)(F)F
Isomeric SMILES OC(=O)c1ccc(cc1)S(=O)(=O)N(c1ncc2c(c1C1CC1)cccc2)Cc1ccc(cc1)OC(F)(F)F
InChI InChI=1S/C27H21F3N2O5S/c28-27(29,30)37-21-11-5-17(6-12-21)16-32(38(35,36)22-13-9-19(10-14-22)26(33)34)25-24(18-7-8-18)23-4-2-1-3-20(23)15-31-25/h1-6,9-15,18H,7-8,16H2,(H,33,34)
InChI Key CWEFDWIKLABKBX-UHFFFAOYSA-N
References
1. Tsuzuki Y, Sawamoto D, Sakamoto T, Kato T, Niwa Y, Awai N. (2012)
Sulfonamide compounds having trpm8 antagonistic activity.
Patent number: WO2012124825. Assignee: Mitsubishi Tanabe Pharma Corporation. Priority date: 16/03/2011. Publication date: 20/09/2012.
2. Weyer AD, Lehto SG. (2017)
Development of TRPM8 Antagonists to Treat Chronic Pain and Migraine.
Pharmaceuticals (Basel), 10 (2). [PMID:28358322]